Table 3.
Cardiophrenic lymph nodes (CPLN) in relation to ovarian cancer subtypes/survival
| n (%) | ||||||
|---|---|---|---|---|---|---|
| Stage I | Advanced Stage | OR (95% CI) | p-val | ORAdja(95% CI) | p-val | |
| CPLN | 0.033 | 0.173 | ||||
| < 5 mm | 13 (72.2) | 32 (43.2) | 1.0 (Ref.) | 1.0 (Ref.) | ||
| ≥5 mm | 5 (27.8) | 42 (56.8) | 3.14 (1.10–10.57) | 2.13 (0.69–7.66) | ||
| Observations | 92 | 90 | ||||
| Low grade | High grade | OR (95% CI) | p-val | ORAdjb(95% CI) | p-val | |
| CPLN | 0.149 | 0.181 | ||||
| < 5 mm | 21 (58.3) | 24 (42.9) | 1.0 (Ref.) | 1.0 (Ref.) | ||
| ≥5 mm | 15 (41.7) | 32 (57.1) | 1.87 (0.80–4.36) | 1.86 (0.75–4.62) | ||
| Observations | 92 | 90 | ||||
| Alive | Dead | HR (95% CI) | p-val | HRAdjc(95% CI) | p-val | |
| CPLN | 0.110 | 0.275 | ||||
| < 5 mm | 24 (57.1) | 22 (42.3) | 1.0 (Ref.) | 1.0 (Ref.) | ||
| ≥5 mm | 18 (42.9) | 30 (57.7) | 1.57 (0.90–2.73) | 1.40 (0.77–2.54) | ||
| Observations | 94 | 90 | ||||
aAdjusted for age at diagnosis and histological type/grade
bAdjusted for age at diagnosis and stage
cAdjusted for age at diagnosis and stage and histological type/grade